2008 annual financial data

Regeneron Pharmaceuticals 2008 Financial results

Direct answer

Revenue was 238,457,000 USD.

Operating income was -89,830,000 USD and net income was -82,710,000 USD.
Operating cash flow was -89,086,000 USD.

Get free Regeneron Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
238,457,000 USD
Operating income
-89,830,000 USD
Net income
-82,710,000 USD
Operating cash flow
-89,086,000 USD